🇺🇸 FDA
Pipeline program

aspirin 100mg/d therapy

006

Approved small_molecule active

Quick answer

aspirin 100mg/d therapy for Coronary Atherosclerosis is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Coronary Atherosclerosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials